Fragility Fracture Clinical Trial
Official title:
Hip Fracture Prevention by Screening and Intervention of Elderly Women in Primary Health Care. 2001 - 2022
Researchers plan a 2022 follow-up of medical records data to investigate fracture incidence and survival for 1248 women, born 1902-1931, in a comparative fracture prevention study with 435 participants from an intervention area and 813 participants from two control areas. In 2022 researchers want to assess patient records data in intervention and control areas and compare A) Survival B) Risk factors for osteoporotic fractures (wrist, upper arm, vertebral, pelvic, hip) C) physical activity, exercise and drugs that affect fracture risk.
Researchers plan a 2022 follow-up of medical records data to investigate fracture incidence and survival for 1248 women, born 1902-1931, in a comparative fracture prevention study with participants from an intervention area (Vislanda, n=435) and control areas (Emmaboda n=395 and Tingsryd (n=418). Fragility fracture prevalence after 40 years of age was 33% in the 1248 participants with mean age 79 years at baseline 2001. Participants with 2-4 risk factors (age ≥80, body weight <60kg, previous fragility fracture or impaired rise-up ability) provided prospective data with FRAMO (FRActure and Mortality) Index as an outcome measure and this index identified 80% of hip, fragility fractures or death within a 2-year follow-up period. Hip fracture incidence 2004-2005 was not significantly lower in the intervention area but the trend of the odds ratio (0.33) was in line with significantly fewer falls and improved recovery in the intervention area. In 2022 researchers want to assess patient records data in intervention and control areas and compare A) Survival B) Risk factors for osteoporotic fractures (wrist, upper arm, vertebral, pelvic, hip) C) physical activity, exercise and drugs that affect fracture risk. Data analysis will be blinded for participation in intervention or control groups and statistical methods include Cox regression and Kaplan-Meier's survival analyzes. Birth cohort differences in outcomes will be analysed by using Lexi's diagrams. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
Active, not recruiting |
NCT05426356 -
Sacral Fracture Fusion/Fixation for Rapid Rehabilitation
|
N/A | |
Recruiting |
NCT05489952 -
Iron Supplementation for Geriatric Hip Fractures
|
Phase 4 | |
Active, not recruiting |
NCT04654962 -
Use of Anesthetic Block for the Prevention of in Hospital Delirium in Patients of the Orthogeriatric Clinical Care Center of the HUFSFB and HUSJI From 2019 - 2020
|
||
Recruiting |
NCT04787679 -
Image-guided Computational and Experimental Analyses of Fractured Patient's Bone (GAP)
|
||
Recruiting |
NCT04657510 -
Femoral frACturEs and COVID-19.
|
||
Not yet recruiting |
NCT06054165 -
Impact of a Clinical Pathway for Pelvic Fragility Fractures
|
N/A | |
Recruiting |
NCT05712616 -
Role of Strontium Ranelate in Proximal Femur Fragility Fractures.
|
Phase 4 | |
Not yet recruiting |
NCT05837182 -
The Role of Augmented Fixation Techniques in Fragility Fracture Pelvis (FFP)
|
||
Recruiting |
NCT05096195 -
PRevEnting FracturEs in REnal Disease 1
|
Phase 4 | |
Completed |
NCT05721898 -
Assessment of Cortical Bone Mechanics Technology (CBMT) Fracture Discrimination Capability
|
||
Recruiting |
NCT06134908 -
PRevention of OsTEoporotiC FracTure 2 Pilot Study
|
N/A | |
Recruiting |
NCT04934358 -
Motivational Interventions and Physical Exercise in Patients With Fragility Fracture
|
N/A | |
Not yet recruiting |
NCT06050668 -
Essential Amino Acid Supplementation for Femoral Fragility Fractures
|
N/A | |
Recruiting |
NCT05851898 -
Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures
|
Phase 4 | |
Recruiting |
NCT04796350 -
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
|
N/A |